UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2022 4:01 P.M.
Form: S-3
CIK: 0001736243
Company Name: Acurx Pharmaceuticals, Inc.
File Number: 333-265956